Tradestie Institutional Equity Comparison Engine

SNYR vs MNMD โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-09-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

MNMD Overall Edge

MNMD Captures Institutional Edge (3โ€“1 Pillars ยท 8โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Mind Medicine (MindMed) Inc. Common Shares (MNMD) driven by superior Growth & Margin, Momentum & Technical, Options & Structure while SNYR counters with relative strength in Valuation. Fundamentally, SNYR trades at 0.6x Forward P/E with -10.3% operating margin (-32.8% YoY revenue) versus MNMD at N/M Forward P/E and 0.0% operating margin (+0.0% YoY). In options structure, SNYR sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro) against MNMD sits in UNCLASSIFIED (6th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner SNYR
SNYR 0.6x vs MNMD N/M Fwd P/E
Growth & Margin Winner MNMD
Op Margin -10.3% vs 0.0% ยท YoY -32.8% vs +0.0%
Momentum & Technical Winner MNMD
1Y -96.2% vs +131.2% ยท 52W Pos 1% vs 98%
Options & Structure Winner MNMD
UNCLASSIFIED (N/A IV) vs UNCLASSIFIED (6th %ile IV)
SNYR NASDAQ
Synergy CHC Corp. Common Stock
Medicinal Chemicals & Botanical Products
$0.09
-67.02% 1D
Market Cap $4.1M
1M Return -16.28%
1Y Return -96.15%
Forward P/E 0.6x
Unified AI Score
48.9 / 100 HOLD
Tech 55.0 Fund 39.0 Flow 50.0 Mom 60.0
MNMD NASDAQ
Mind Medicine (MindMed) Inc. Common Shares
Medicinal Chemicals & Botanical Products
$15.02
+1.01% 1D
Market Cap $1.4B
1M Return +19.54%
1Y Return +131.25%
Forward P/E N/M
Unified AI Score
63.1 / 100 BUY
Tech 75.0 Fund 62.0 Flow 60.0 Mom 50.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: SNYR -96.15% MNMD +131.25% Spread: +77.24 pp (MNMD Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
SNYR TTM Op. Margin: -10.3% MNMD TTM Op. Margin: 0.0%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on SNYR vs MNMD. Trailing 12-month operating profitability (SNYR -10.3% vs MNMD 0.0%) and valuation multiples (SNYR 0.6x vs MNMD N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: SNYR (2) vs MNMD (8)
Institutional Metric SNYR MNMD Criterion Row Winner
Market Capitalization Scale $4.1M $1.4B Larger Scale MNMD
Trailing P/E Ratio Valuation 0.6x N/M Lower Multiple SNYR
Forward P/E Ratio Valuation 0.6x N/M Lower Multiple SNYR
Revenue Growth (YoY) Growth -32.8% +0.0% Higher Growth MNMD
Operating Margin (TTM) Profitability -10.3% 0.0% Higher Margin MNMD
Net Profit Margin Profitability -57.0% 0.0% Higher Margin MNMD
Return on Equity (ROE) Capital Efficiency -361.1% -85.6% Higher ROE MNMD
52-Week Range Position Momentum 1% ($0โ€“$3) 98% ($5โ€“$15) Stronger Trend MNMD
Beta / 30D Volatility Risk Regime -0.86ฮฒ ยท 868% Vol 1.79ฮฒ ยท 55% Vol Lower Realized Risk MNMD
Unified Institutional Score Composite Signal 48.9 / 100 (HOLD) 63.1 / 100 (BUY) Higher Composite MNMD

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full SNYR vs MNMD Buy Guide
SNYR UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live SNYR Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MNMD UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 6th %ile
IV Regime Compressed (<25th %ile)
Live MNMD Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither SNYR nor MNMD registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.